This study is looking at how using a special ultrasound score, called VExUS (Venous Excess Ultrasound), can help doctors manage fluids in critically ill patients in the ICU who have acute kidney injury (AKI). You would be in one of two groups: one where your care team gets recommendations based on your VExUS score for fluid management, or another where they don't. The study aims to see if using VExUS to guide fluid balance (how much fluid you receive or lose) can improve important outcomes like survival, the need for kidney dialysis (renal replacement therapy), and long-term kidney function. We are looking for 100 adult patients who are in the ICU with AKI.

Study design

This is an interventional study with 100 participants, combining observational and randomized components. It compares two groups: one where doctors receive VExUS recommendations and one where they do not.

What's involved

You would undergo two VExUS ultrasound assessments: one at enrollment and another 48-72 hours later. Blood tests and fluid balance records would also be collected.

Compensation

Not stated in the trial record.

Follow-up

Your in-hospital mortality, need for renal replacement therapy, and persistent renal dysfunction will be measured for up to 30 days.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.